“Time & Extent” Botanical Candidates To Lead Off With Ginger, Valerian?
This article was originally published in The Tan Sheet
Executive Summary
Ginger and valerian are promising prospects for FDA determinations on OTC drug monograph eligibility under the "material time, material extent" final rule
You may also be interested in...
FDA “Material Time, Material Extent” Rule May Be Cloudy For Sunscreens
Interim marketing for OTC drugs or "conditions" in the U.S. subject to a final or new monograph is barred under FDA's final rule on "material time, material extent" criteria
Monograph Eligibility To Include U.S. Rx-Only Drugs With Foreign OTC Data
A drug marketed OTC in foreign countries but limited to Rx use in the U.S. could be considered for eligibility in the OTC monograph system under FDA's final rule on "material time, material extent" criteria, published in the Federal Register Jan. 23
OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs
Sponsors of OTC drugs with extensive foreign marketing experience need not provide detailed information from each country in requesting the drug or "condition" be considered for OTC monograph eligibility in the U.S., FDA says